相关实验视频
Updated: Jul 15, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.6K
基斯调节剂KAT2A作为与瘤微环境相关的潜在生物标志物,以及扩散大B细胞淋巴瘤的预后
Zhuoya Yu1, Mengfei Ding1, Yiqing Cai1
1Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
BMC cancer
|October 3, 2023
概括
基素乙化模式对扩散性大B细胞淋巴瘤 (DLBCL) 的进展产生影响. 一个新的HAscore模型和KAT2A显示出诊断免疫状况和指导DLBCL治疗的潜力.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 表观遗传改变是淋巴瘤发病的关键驱动因素.
- 激素乙化,一个关键的表观遗传机制,影响基因转录.
- 异常的基因组乙化显著影响扩散性大B细胞淋巴瘤 (DLBCL) 的进展及其瘤微环境.
研究的目的:
- 为了研究素乙化模式在DLBCL中的作用.
- 开发一个模型来评估DLBCL中的基因素乙化.
- 探索KAT2A在DLBCL细胞行为中的功能.
主要方法:
- 开发一个HAscore模型来分析DLBCL中的基因素乙化模式.
- 在DLBCL细胞系中,基因对KAT2A (一种基因素乙化调节剂) 的敲除.
- 评估KAT2A敲除后的增殖,细胞循环和细胞亡.
主要成果:
- 哈斯科尔模型与DLBCL患者的独特瘤免疫微环境和预后相关.
- 低HAscore与较差的患者结果有关.
- KAT2A被确定为与DLBCL免疫透和恶性途径相关的潜在生物标志物.
结论:
- 组织素乙化模式得分模型有助于理解DLBCL免疫状态.
- 作为DLBCL治疗策略的生物标志物,KAT2A显示出希望.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Histone Variants at the Centromere
4.4K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Histone Modification
13.4K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

